Company News

 

May 17, 2002

Notice regarding Repurchase of Ono Pharmaceutical's Own Shares
(Under Article 210 of Japanese Commercial Code)
At today's Board of Directors meeting, Ono Pharmaceutical Co., Ltd. decided to call for a shareholders' resolution on the repurchase of its own shares, at the 54th general meeting of shareholders to be held on June 27, 2002, based on Article 210 of the Japanese Commercial Code.
     1. Reason for share repurchase:

To implement its corporate policy, responding to a diversified corporate environment with greater flexibility

     2. Details of proposed share repurchase:

(1) Type of shares to be acquired : Common stock
(2) Total number of shares to be acquired : 5,000,000 shares (maximum)
(3) Total value of shares to be acquired : ¥24,000,000,000 (maximum)


      (Note)
     The above repurchase of its own shares requires approval at the 54th general meeting of shareholders to be held on June 27, 2002 for actual implementation, which is scheduled during a period from the approval to the next general meeting of shareholders.

      Corporate Information
     Corporate name : Ono Pharmaceutical Co., Ltd.
     Representative : Toshio Ueno, Chairman and CEO
     Stock code : 4528
     Stock listings : First sections of Tokyo Stock Exchange and Osaka Securities Exchange
     Inquiries : Kinya Morimoto, Director, Public Relations
     Tel. : +81-6-6222-5551